Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
With once-daily liraglutide, another GLP-1 receptor agonist approved for the treatment of type 2 diabetes at doses of up to 1.8 mg, body weight and sex were found to be the most important covariates for exposure which, however, did not influence liraglutide PK to any clinically relevant degree [13]
Most researchers order a monthly supply at a time
Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist used for type 2 diabetes and chronic weight management
Tirzepatide, a dual GLP-1 and GIP receptor agonist, effectively reduces appetite and promotes weight lossbut some patients experience sulfur-smelling burps during their first weeks of treatment
US$ 22.90
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 20.43
US$ 24.90
US$ 22.27
US$ 25.71
US$ 27.99
